The Cardiovascular Council consists of Society members interested in the performance and application of cardiovascular nuclear medicine procedures. It seeks to provide a forum for discussion and development of cardiac scintigraphic methods in an effort to realize the most beneficial applications. The Council actively seeks individuals who share this goal.


Terrence D. Ruddy, MD, FRCPC, FACC, FAHA, FCCS
Cardiovascular Council President







Dear Colleagues,

At the SNMMI Annual Meeting in Philadelphia, I had the honor of succeeding Dr. Panithaya Chareonthaitawee as President of the Cardiovascular Council (CVC).  I thank all of the members of the CVC for your ongoing support and look forward to our continued success.

We are all grateful to our Immediate Past-President, Dr. Panithaya Chareonthaitawee, for her leadership over the last year.  Her management style, an ‘iron fist in a velvet glove’, was highly effective with many significant achievements; including the successful Mid-Winter and Annual Meetings, and the joint SNMMI/ASNC publications on ‘The Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring’ ( and ‘Clinical Quantification of Myocardial Blood Flow’ (  She gently and effectively engaged and encouraged the Council to achieve our goals and exceed our expectations.  She furthered our efforts for outreach to other cardiovascular imaging societies by collaboration on joint statements and encouraging participation and co-sponsorship in our educational programs.

The 2018 SNMMI Annual Meeting was outstanding.  The CVC was well represented with the Categorical Session ‘Case-Based Review of Advanced Cardiovascular Imaging’ and numerous Continuing Education Sessions with topics ranging from ‘Measurement of Myocardial Blood Flow’ to ‘Cardiovascular Molecular Imaging’.  The CVC sponsored sessions were well attended and received excellent evaluations.

We are looking forward to the 2019 SNMMI Mid-Winter Meeting on January 17-19 in sunny Palm Springs, California.  The featured theme is ‘Cardiovascular Nuclear Medicine’ with ten sessions and 40 presentations sponsored by the CVC.  Topics begin with a refresher on basic concepts of stress testing and move on to exciting new areas of research and discovery.  World renowned speakers will discuss multimodality imaging of amyloidosis, sarcoidosis and infection of cardiac valves, PET measurement of myocardial blood flow and NaF PET imaging of valvular and coronary vascular disease. All presentations will be case-based with much emphasis and time allotted for audience and speaker interaction.

This is an exciting time to be a professional in Cardiovascular Nuclear Medicine.  PET myocardial perfusion imaging is becoming established as an important clinical tool for patient care and is now reimbursed in the USA and Canada.  Cardiac nuclear imaging has evolved and now includes detection and monitoring of amyloidosis, sarcoidosis, vasculitis and infection of cardiac valves and devices.  We are well positioned to assist and direct delivery of optimized patient-centered care.   We are meeting the challenges of changing reimbursement models and facilitating the development of Appropriate Use Criteria for selection of cardiac nuclear testing.

I am sure that we are all looking forward to the Mid-Winter Meeting in Palm Springs, California and the opportunity for learning from the experts and relaxing in the sun.


Cardiovascular Statistics and Imaging Guidelines

  1. Heart Disease and Stroke Statistics: 2016 Update; A Report from the American Heart Association
  2. Approaches to Enhancing Radiation Safety in Cardiovascular Imaging: A Scientific Statement From the American Heart Association
  3. Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Ischemic Heart Disease: A Consensus Statement From the American Heart Association
  4. 2013 ACCF/ACR/ASE/ASNC/SCCT/SCMR Appropriate Use of Cardiovascular Imaging in Heart Failure; A Joint Report of the ACR Appropriate Criteria Committee and the ACC Foundation AUC Task Force
  5. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 Multimodality Appropriate Use Criteria for the Detection and Risk Assessment of Stable Ischemic Heart Disease
  6. All Guidelines from the American College of Cardiology can be accessed here
  7. The SNMMI’s guideline documents for the cardiovascular system can be accessed here
  8. The SNMMI's full suite of guidance on Dose Optimization is available here

The Society recognizes the need for sub-specialty interests/expertise within the field of nuclear medicine and moleuclar imaging. Councils provide the expertise, professional networking and educational programs for nuclear medicine professionals in respective areas and serve as a resource for development and implementatin of Society policies.

Council membership is voluntary. Councils adhere to Society Bylaws and policies, while operating under its own Operating Procedures, as approved by the House of Delegates, and its own business plan and budget, as approved by the SNMMI Board of Directors.

This secion provides the following council specific information.

Cardiovascular Council Board of Directors

CVC Operating Procedures

CVC Business Plan

CVC Council Reports to the House of Delegates

CVC Past Presidents


The Cardiovascular Council (CVC) works to serve and be a resource for members of the council itself who have special interest and expertise in the field of cardiovascular nuclear medicine, as well as to SNMMI as a whole in its missions and endeavors. 

As part of its mission, the CVC organizes scientific and continuing education sessions at the Mid Winter Meeting and the Annual Meeting of the Society. These activities are for members of the council and for the SNMMI membership at large, and they are also open to participation and attendance by people from outside the SNMMI. The CVC also supports additional programs on specialized topics, such as cardiac PET/CT, CV Molecular Imaging and Cost Effectiveness Research.  News and activities of the CVC are circulated to council members in a semi-annual newsletter. This and other professional information will also be available through the CVC webpage, and efforts underway to expand awareness of cardiovascular nuclear medicine studies to patients and providers via Outreach links through the SNMMI website.


Don’t Wait! Join Now!

The investment to join the Cardiovascular Council is minimal – only $20 annually.  Your membership dollars help us immensely in sponsoring quality programs while promoting medical education, research and patient care related to Cardiovascular Nuclear Medicine.  

You can join online at or send an email to




Cardiovacular Council Announcements

Register today!

The 2019 SNMMI Mid-Winter and ACNM Annual Meeting will be held

January 17-19 in Palm Springs, California

Join the CVC for the Nuclear Cardiology track, including these sessions:  New Frontiers in Nuclear Cardiology, Evaluation of Cardiac Sarcoidosis, Starting a PET Program; PET Myocardial Blood Flow: Nuts and Bolts, Nuts and Bolts of Stress Perfusion Imaging, Improving Value and Quality in Cardiovascular Nuclear Medicine, Cardiac Amyloidosis Imaging, Clinical Controversies Relevant to Cardiovascular Imaging, Cardiovascular Inflammation & Infection Imaging, Myocardial Viability Assessment



Join this Council

The cost to join this council is $20.00.

Modify Your Membership (Login Required)

- OR -

You can join online at or send an email to

CVC Events

2019 Mid-Winter Meeting - Nuclear Cardiology Track

New Frontiers in Nuclear Cardiology
Thursday, January 17, 1:30 – 3:30pm

  • Quantification of MBF with SPECT – Terrence Ruddy, MD
  • Machine Learning for Cardiac SPECT – Piotr Slomka, PhD
  • New Scanners for Cardiac SPECT – R. Glenn Wells, PhD
  • NaF PET Imaging of the Cardiovascular System – Marc Dweck, MD

Evaluation of Cardiac Sarcoidosis
Thursday, January 17, 3:45 – 5:45pm

  • Detection and Monitoring using FDG PET for Sarcoidosis – Panithaya Chareonthaitawee, MD
  • Techniques for and Advantages of Image Quantification – Piotr Slomka, PhD
  • Interpretation and Reporting: Step by Step Approach – Thomas Schindler, MD
  • PET, CMR or Both – Marc Dweck, MD

Cardiac PET/CT Cases Workshop
Thursday, January 17, 6:30 – 8:30pm

  • Cardiac PET CT Cases – Hayan Jouni, MD

Starting a PET Program
Friday, January 18, 8:00 – 10:00am

  • PET Tracers & Cameras for Cardiac PET – Heinrich Schelbert, MD, PhD
  • Importance of FDG for Viability and Inflammation Imaging – Wengen Chen, PhD
  • Design of Facilities and Implementation – Timothy Bateman, MD
  • Patient Selection for Cardiac SPECT vs. PET – Edward Miller, MD, PhD

PET Myocardial Blood Flow: Nuts and Bolts
Friday, January 18, 10:15am – 12:15pm

  • Tracers and Imaging Protocols – Richard Weinberg, MD, PhD
  • Clinical Implications – Terrence Ruddy, MD
  • Quality Control and Reporting – Venkatesh Murthy, MD
  • New Flow Tracer: Flurpiridaz – Timothy Bateman, MD

Nuts and Bolts of Stress Perfusion Imaging
Friday, January 18, 1:15 – 3:15pm

  • Stress Electrocardiography: Basics and Beyond the ST Segment – Richard Weinberg, MD, PhD
  • Protocols for Stress Testing: Importance of Symptom Limited Exercise – Jamieson Bourque, MD
  • Cases in Nuclear MPI: Optimizing Interpretation and Correlation with Non-Nuclear Modalities – Diwakar Jain, MD, FSNMMI
  • Optimizing Quality in Nuclear MPI: Detecting and Avoiding Artifacts – April Mann, MBA, CNMT, NCT

Improving Value and Quality in Cardiovascular Nuclear Medicine
Friday, January 3:45 – 5:45pm

  • Importance of Lower Radiation Exposures and How to Get There – R. Glenn Wells, PhD
  • High Value Reporting in Cardiac Nuclear Medicine – Prem Soman, MD, PhD
  • Appropriate Use Criteria and ICANL Accreditation – Jamieson Bourque, MD
  • Implementation of QA Programs – April Mann, MBA, CNMT, NCT

Cardiac Amyloidosis Imaging
Saturday, January 19, 8:00 – 10:00am

  • Clinical Aspects of Cardiac Amyloidosis – Prem Soman, MD, PhD
  • Planar and SPECT Imaging for Cardiac Amyloidosis – Brett Sperry, MD
  • CMR for Cardiac Amyloidosis – Munir Ghesani, MD
  • Novel PET Approaches for Cardiac Amyloidosis – Sharmila Dorbala, MD, MPH

Clinical Controversies Relevant to Cardiovascular Imaging
Saturday, January 19, 10:30am – 12:30pm

  • Does Ischemia Matter? – Venkatesh Murthy, MD
  • Should Calcium Score be a Gatekeeper to Stress Testing – Edward Miller, MD, PhD
  • Should Testing in Women be Different? – Sharmila Dorbala, MD, MPH
  • Is there a Role for Nuclear Screening of Asymptomatic Patients (Case-Based) – Diwakar Jain, MD, FSNMMI

Cardiovascular Inflammation & Infection Imaging
Saturday, January 19, 1:30 – 3:30pm

  • Metabolic Preparation and Imaging Protocols for FDG PET/CT Imaging of Cardiac Device Infection – Asbjorn Scholtens, MD
  • FDG PET/CT for Endocarditis Evaluation – Vasken Dilsizian, MD
  • FDG PET/CT for LVAD Infection Imaging – Wengen Chen, PhD
  • Aortitis Imaging – Munir Ghesani, MD

Myocardial Viability Assessment
Saturday, January 19, 4:00 – 6:00pm

  • Patient Preparation & Image Acquisition – Brett Sperry, MD
  • Does Viability Matter Clinically? – Heinrich Schelbert, MD, PhD
  • FDG For Evaluation of Arrhythmias - Vasken Dilsizian, MD
  • PET versus CMR or Both? – Thomas Schindler, MD



2018 Annual Meeting - CVC CE Sessions:

  • FDG PET Assessment of Viability and Inflammation
  • How to Establish a Cardiac PET Program
  • Cardiovascular Boot Camp I
  • Cardiovascular Boot Camp II
  • Cardiovascular Molecular Imaging
  • Cardiovascular Imaging with Novel Radiotracers:  Looking Beyond Perfusion Imaging
  • Measurement of Absolute Myocardial Blood Flow – Part I (joint session with CaIC)
  • Measurement of Absolute Myocardial Blood Flow, Part II:  Current State of Dynamic SPECT (Joint session with CVC)
  • Hermann Blumgart Award Session